Please assess the completion status of the following clinical trial:

Trial Title: Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patient Participant Inclusion Criteria~* Age greater than 18 years~* Diagnosis of cancer with a new or existing prescription for oral chemotherapy~* Receiving cancer care at either Massachusetts General Hospital Cancer Center or community affiliates (North Shore or Emerson Hospitals)~* Eastern Cooperative Oncology Group (ECOG) ranging from 0 (asymptomatic) to 2 (symptomatic and in bed \>50% of the day)~* Able to read and respond to questions in English~* Uses smart mobile phone (either operating system (iOS) \[iPhone\] or Android device)~Clinician Participant Inclusion Criteria - Clinician participants must be oncology clinicians (i.e. physicians and nurse practitioners) who maintain at least 25% clinical practice at the Massachusetts General Hospital Cancer Center or one of its community affiliates at the North Shore or Emerson Hospital.~Stakeholder Participant Inclusion Criteria - Four groups of stakeholders will provide ongoing feedback about the study design, methods, and results. To be eligible as a stakeholder, the participant must be able to represent the interests and perspective of at least one of the following stakeholder groups:~* Oncology Patient or Family Member~* Oncology Clinician (e.g., Physician or Nurse Practitioner)~* Cancer Practice Setting Administrator Health System, Community, and Society.~Exclusion Criteria:~Patient Participant Exclusion Criteria~* Individuals with co-morbid acute or untreated psychiatric symptoms (e.g., psychosis) or neurologic dysfunction will be excluded given that such symptoms would interfere with consent and participation.~* Individuals who own Windows or Blackberry smart mobile phones will not be eligible.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Mobile Application Intervention (Type: EXPERIMENTAL): Participants in the intervention group will receive the mobile application for improving symptoms and adherence to oral chemotherapy along with their standard oncology care. The proposed elements of the mobile application include the following: 1) specification of an oral chemotherapy treatment plan; 2) weekly collection of patient-reported symptoms and medication adherence; and 3) delivery of real-time, tailored feedback to patients as well as immediate transmission of survey results to oncology clinicians.
- Standard Oncology Care (Type: NO_INTERVENTION): Participants in the control group will receive standard oncology care only.

Based on this trial design, predict the completion outcome and termination type (if applicable).